These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20615188)

  • 1. Development of aminoglycoside antibiotics effective against resistant bacterial strains.
    Yang L; Ye XS
    Curr Top Med Chem; 2010; 10(18):1898-26. PubMed ID: 20615188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative Pathogens.
    Matsushita T; Sati GC; Kondasinghe N; Pirrone MG; Kato T; Waduge P; Kumar HS; Sanchon AC; Dobosz-Bartoszek M; Shcherbakov D; Juhas M; Hobbie SN; Schrepfer T; Chow CS; Polikanov YS; Schacht J; Vasella A; Böttger EC; Crich D
    J Am Chem Soc; 2019 Mar; 141(12):5051-5061. PubMed ID: 30793894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.
    Zimmermann L; Das I; Désiré J; Sautrey G; Barros R S V; El Khoury M; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2016 Oct; 59(20):9350-9369. PubMed ID: 27690420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance.
    Shaul P; Green KD; Rutenberg R; Kramer M; Berkov-Zrihen Y; Breiner-Goldstein E; Garneau-Tsodikova S; Fridman M
    Org Biomol Chem; 2011 Jun; 9(11):4057-63. PubMed ID: 21365081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
    Yan RB; Yuan M; Wu Y; You X; Ye XS
    Bioorg Med Chem; 2011 Jan; 19(1):30-40. PubMed ID: 21177112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of aminoglycoside resistance activated in cells.
    Vong K; Tam IS; Yan X; Auclair K
    ACS Chem Biol; 2012 Mar; 7(3):470-5. PubMed ID: 22217014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity modulation, resistance enzyme evasion, and A-site X-ray structure of broad-spectrum antibacterial neomycin analogs.
    Maianti JP; Kanazawa H; Dozzo P; Matias RD; Feeney LA; Armstrong ES; Hildebrandt DJ; Kane TR; Gliedt MJ; Goldblum AA; Linsell MS; Aggen JB; Kondo J; Hanessian S
    ACS Chem Biol; 2014 Sep; 9(9):2067-73. PubMed ID: 25019242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and molecular basis for resistance to aminoglycoside antibiotics by the adenylyltransferase ANT(2″)-Ia.
    Cox G; Stogios PJ; Savchenko A; Wright GD
    mBio; 2015 Jan; 6(1):. PubMed ID: 25564464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycosides with Anti-MRSA Activity: A Concise Review.
    Yao CJ; Li YL; Pu MJ; Luo LH; Xiong Q; Xie FJ; Li TL; Feng PM
    Curr Top Med Chem; 2021; 21(27):2483-2499. PubMed ID: 34607544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.
    Labby KJ; Garneau-Tsodikova S
    Future Med Chem; 2013 Jul; 5(11):1285-309. PubMed ID: 23859208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Induction of Aminoglycoside Uptake Overcomes Antibiotic Tolerance and Resistance in Staphylococcus aureus.
    Radlinski LC; Rowe SE; Brzozowski R; Wilkinson AD; Huang R; Eswara P; Conlon BP
    Cell Chem Biol; 2019 Oct; 26(10):1355-1364.e4. PubMed ID: 31402316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors.
    Zárate SG; De la Cruz Claure ML; Benito-Arenas R; Revuelta J; Santana AG; Bastida A
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29385736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside microarrays to study antibiotic resistance.
    Disney MD; Magnet S; Blanchard JS; Seeberger PH
    Angew Chem Int Ed Engl; 2004 Mar; 43(12):1591-4. PubMed ID: 15022242
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective modification of the 3''-amino group of kanamycin prevents significant loss of activity in resistant bacterial strains.
    Santana AG; Zárate SG; Asensio JL; Revuelta J; Bastida A
    Org Biomol Chem; 2016 Jan; 14(2):516-525. PubMed ID: 26501183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aminoglycosides on the pathogenic characteristics of microbiology.
    Xu Z; Xu X; Qi D; Yang L; Li B; Li L; Li X; Chen D
    Microb Pathog; 2017 Dec; 113():357-364. PubMed ID: 28867624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside antibiotics in the 21st century.
    Becker B; Cooper MA
    ACS Chem Biol; 2013 Jan; 8(1):105-15. PubMed ID: 23110460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating aminoglycoside antibiotics to reduce their toxic side effects.
    Rosenberg CR; Fang X; Allison KR
    PLoS One; 2020; 15(9):e0237948. PubMed ID: 32877437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes.
    Boehr DD; Draker KA; Koteva K; Bains M; Hancock RE; Wright GD
    Chem Biol; 2003 Feb; 10(2):189-96. PubMed ID: 12618191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Studies of an Aminoglycoside Potentiator Reveal a New Inhibitor of Aminoglycoside Resistance.
    Guan J; Vong K; Wee K; Fakhoury J; Dullaghan E; Auclair K
    Chembiochem; 2018 Oct; 19(19):2107-2113. PubMed ID: 30059603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targets for design of novel inhibitors to circumvent aminoglycoside resistance.
    Jana S; Deb JK
    Curr Drug Targets; 2005 May; 6(3):353-61. PubMed ID: 15857293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.